From Doctor to Drug Developer: Dr. Akhil Kumar | CMO Aurigene

From Doctor to Drug Developer: Lessons in Clinical Development & Biotech Leadership | Akhil Kumar

🎙️ Mentor Konnect | BioPatrika Mentorship Session


🎥 Watch the Full Session


About This Episode

In this insightful Mentor Konnect session, BioPatrika hosts Dr. Akhil Kumar, Chief Medical Officer at Aurigene Discovery Technologies, who shares his remarkable journey from clinical medicine to global drug development leadership.

With over 20+ years of experience across big pharma and biotech, Dr. Kumar has contributed to multiple IND applications and successful FDA approvals, and has played a key role in building clinical development capabilities in India.

This session provides a rare behind-the-scenes look into how drugs are developed, why most fail, and what it takes to succeed in the biopharma industry.


Key Highlights from the Session

🔬 Transition from Medicine to Industry

Dr. Kumar reflects on his journey from AIIMS-trained physician to working in global pharma, highlighting the steep learning curve and the shift from a hierarchical clinical system to a collaborative R&D environment.

⚖️ The Reality of Drug Development

One of the most powerful takeaways:
👉 Success in drug development is rare. Most programs fail—but each failure builds critical learning.

He shares how working on multiple programs—both successful and unsuccessful—shaped his understanding of science, risk, and decision-making.

🌍 US vs India Biotech Ecosystems

The session dives into differences between global and Indian biotech environments, including:

  • Talent availability
  • Infrastructure challenges
  • Speed of innovation
  • Opportunities for growth in India

🧬 Building Clinical & CGT Capabilities

At Aurigene, Dr. Kumar established:

  • A clinical development department from scratch
  • A Cell & Gene Therapy (CGT) vertical
  • A GMP facility supporting clinical trials

This highlights India’s growing role in advanced therapeutics and translational research.

🤝 Power of Cross-Functional Teams

Drug development is never a solo effort. He emphasized working across:

  • Pharmacology
  • Pharmacokinetics
  • Toxicology
  • Clinical teams

True innovation happens at the intersection of disciplines.


Career Lessons for Aspiring Scientists

💡 Be ready to start over: Transitioning into industry often feels like beginning from scratch.
💡 Embrace failure: It is an integral part of drug development.
💡 Think beyond your domain: Collaboration is key.
💡 Stay resilient: The first few years define long-term success.


Why This Session Matters

Whether you are:

  • A PhD student or postdoc exploring industry
  • A clinician considering pharma careers
  • A biotech professional aiming for leadership roles

This session offers practical, real-world insights into clinical development, leadership, and career transitions.


About Mentor Konnect

Mentor Konnect by BioPatrika is a platform designed to connect aspiring professionals with leaders across academia, industry, and entrepreneurship—providing direct access to real stories, guidance, and mentorship.


Session Credits

🎙️ Host: Narendra Chirmule, CEO, SymphonyTech Biologics
🎬 Produced by: BioPatrika
🎶 Music: Aditya Sutar


Follow BioPatrika

🌐 https://www.biopatrika.com
💼 https://www.linkedin.com/company/biopatrika
📩 https://www.linkedin.com/newsletters/biopatrika-6915078341121191936/


💬 What stood out most to you—success, failure, or resilience in drug development? Share your thoughts below!

Biopatrika News Desk
Biopatrika News Deskhttp://www.biopatrika.com
Life science news, jobs, careers, fellowships, admissions, and interviews. BioPatrika covers academia, startups, and industry, bridging the gap between science and society

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

600FansLike
707FollowersFollow
4,757FollowersFollow
995SubscribersSubscribe
- Advertisement -spot_imgspot_img

Latest Articles